DK2413899T3 - Dentalt anæstetikum omfattende tetracain og en vasokonstriktor til intranasal indgivelse - Google Patents

Dentalt anæstetikum omfattende tetracain og en vasokonstriktor til intranasal indgivelse Download PDF

Info

Publication number
DK2413899T3
DK2413899T3 DK10714119.4T DK10714119T DK2413899T3 DK 2413899 T3 DK2413899 T3 DK 2413899T3 DK 10714119 T DK10714119 T DK 10714119T DK 2413899 T3 DK2413899 T3 DK 2413899T3
Authority
DK
Denmark
Prior art keywords
vasoconstrictor
tetracaine
intranasal administration
dental anesthetic
anesthetic
Prior art date
Application number
DK10714119.4T
Other languages
Danish (da)
English (en)
Inventor
Mark David Kollar
Original Assignee
St Renatus Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St Renatus Llc filed Critical St Renatus Llc
Application granted granted Critical
Publication of DK2413899T3 publication Critical patent/DK2413899T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245Amino benzoic acid types, e.g. procaine, novocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4174Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M19/00Local anaesthesia; Hypothermia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Emergency Medicine (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK10714119.4T 2009-04-03 2010-04-02 Dentalt anæstetikum omfattende tetracain og en vasokonstriktor til intranasal indgivelse DK2413899T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16668009P 2009-04-03 2009-04-03
PCT/US2010/001002 WO2010114622A1 (en) 2009-04-03 2010-04-02 Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration

Publications (1)

Publication Number Publication Date
DK2413899T3 true DK2413899T3 (da) 2021-04-19

Family

ID=42164462

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10714119.4T DK2413899T3 (da) 2009-04-03 2010-04-02 Dentalt anæstetikum omfattende tetracain og en vasokonstriktor til intranasal indgivelse

Country Status (18)

Country Link
US (7) US8580282B2 (https=)
EP (1) EP2413899B1 (https=)
JP (3) JP5788864B2 (https=)
KR (2) KR20170026639A (https=)
CN (2) CN102421416B (https=)
AU (2) AU2010232995C1 (https=)
BR (1) BRPI1010303A2 (https=)
CA (1) CA2757032C (https=)
DK (1) DK2413899T3 (https=)
EA (1) EA024184B1 (https=)
ES (1) ES2861064T3 (https=)
IL (1) IL215489A0 (https=)
MX (1) MX2011010445A (https=)
NZ (2) NZ612063A (https=)
PL (1) PL2413899T3 (https=)
PT (1) PT2413899T (https=)
WO (1) WO2010114622A1 (https=)
ZA (2) ZA201107011B (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170026639A (ko) 2009-04-03 2017-03-08 세인트 레나투스, 엘엘씨 비강 투여를 위한 테트라카인 및 혈관수축제를 포함하는 치과용 마취제
EP2903604A1 (en) * 2012-09-28 2015-08-12 St. Renatus, LLC Pharmaceutical composition comprising benzyl alcohol for the treatment of migraines
US20180193462A1 (en) * 2014-01-01 2018-07-12 Real Time Imaging Technologies, Llc Improved local anesthetic solution for dental and/or contrast media use
AU2015277272A1 (en) * 2014-06-16 2017-01-12 Loewi LLC Methods of anesthetizing nerve tissue in the trigeminal nerve pathway and medical uses thereof
CN107249568A (zh) * 2014-12-23 2017-10-13 圣雷纳图斯有限责任公司 基于丁卡因的麻醉药
EP3244800A1 (en) 2015-01-12 2017-11-22 Real Time Imaging Technologies, LLC Low-dose x-ray imaging system
US10039830B2 (en) * 2016-03-04 2018-08-07 Cetylite Industries, Inc. Topical anesthetic composition
US20170360718A1 (en) * 2016-06-01 2017-12-21 St. Renatus, Llc Intranasal dental anesthetic
EP3897603A4 (en) 2018-12-19 2022-09-14 Grace Therapeutics Inc. THERAPEUTIC COMPOSITION OF INTRANASAL LIDOCAINE
CN111494310A (zh) * 2020-04-29 2020-08-07 周晓玲 一种局部麻醉药物的制备及使用方法
WO2024151854A1 (en) * 2023-01-13 2024-07-18 Smilanich Michael D Composition for local anesthesia and uses thereof
GB2628149A (en) * 2023-03-16 2024-09-18 Lee Nathaniel Wurie Nasal spray for performing sphenopalatine ganglion block

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3832460A (en) * 1971-03-19 1974-08-27 C Kosti Anesthetic-vasoconstrictor-antihistamine composition for the treatment of hypertrophied oral tissue
US5209724A (en) 1988-04-11 1993-05-11 Dhaliwal Avtar S Composite anesthetic article and method of use
AU4673993A (en) 1992-07-28 1994-02-14 Procter & Gamble Company, The Pharmaceutical composition for topical use containing a crosslinked cationic polymer and an alkoxylated ether
WO1995013810A1 (en) 1993-11-19 1995-05-26 Schering-Plough Healthcare Products Incorporated Nasal spray compositions containing oxymetazoline
US5585398A (en) * 1994-07-15 1996-12-17 Ernst; Amy A. Topical anesthetic comprising lidocaine, adrenaline, and tetracaine, and its method of use
US6075059A (en) 1999-02-24 2000-06-13 The Ohio State University Compositions for dental anesthesia
US20040131665A1 (en) * 1999-10-22 2004-07-08 Wepfer Scott T. Topical anesthetic formulation
US6413499B1 (en) * 2000-01-06 2002-07-02 Bryan M. Clay Methods and kits for maxillary dental anesthesia by means of a nasal deliverable anesthetic
US20040045546A1 (en) 2002-09-05 2004-03-11 Peirce Management, Llc Pharmaceutical delivery system for oral inhalation through nebulization consisting of inert substrate impregnated with substance (S) to be solubilized or suspended prior to use
JP4591746B2 (ja) 2002-12-03 2010-12-01 大正製薬株式会社 難溶性抗ウイルス成分含有水溶性外用剤組成物
ES2223277B1 (es) * 2003-06-19 2006-03-01 Fernando Bouffard Fita Composicion anestesica para administracion topica.
EA009669B1 (ru) 2004-01-01 2008-02-28 Панацея Биотек Лтд. Фармацевтические композиции, содержащие экстракт euphorbia prostrata
US20060052305A1 (en) * 2004-05-10 2006-03-09 Nastech Pharmaceutical Company Inc. Method of treating osteoporosis using intranasal parathyroid hormone
US20070154402A1 (en) 2005-10-24 2007-07-05 Collegium Pharmaceutical, Inc. Topical Pharmaceutical Foam Composition
US9252862B2 (en) 2008-09-17 2016-02-02 Qualcomm Incorporated MIMO preamble for initial access with an unknown number of transmit antennas
KR20170026639A (ko) * 2009-04-03 2017-03-08 세인트 레나투스, 엘엘씨 비강 투여를 위한 테트라카인 및 혈관수축제를 포함하는 치과용 마취제

Also Published As

Publication number Publication date
CN103932973A (zh) 2014-07-23
CA2757032A1 (en) 2010-10-07
US8580282B2 (en) 2013-11-12
CN102421416B (zh) 2014-05-28
US9308191B2 (en) 2016-04-12
CA2757032C (en) 2022-06-07
JP5788864B2 (ja) 2015-10-07
EA024184B1 (ru) 2016-08-31
JP2012522783A (ja) 2012-09-27
EP2413899B1 (en) 2021-01-27
US20170326112A1 (en) 2017-11-16
JP2017031226A (ja) 2017-02-09
US10456377B2 (en) 2019-10-29
US10420750B2 (en) 2019-09-24
CN103932973B (zh) 2017-08-11
AU2010232995A1 (en) 2011-10-20
KR20120042729A (ko) 2012-05-03
NZ595376A (en) 2013-09-27
KR20170026639A (ko) 2017-03-08
ZA201309321B (en) 2016-07-27
CN102421416A (zh) 2012-04-18
ES2861064T3 (es) 2021-10-05
AU2015242984B2 (en) 2017-09-14
US20120039960A1 (en) 2012-02-16
JP2015034167A (ja) 2015-02-19
IL215489A0 (en) 2011-12-29
US9855247B2 (en) 2018-01-02
PL2413899T3 (pl) 2021-09-20
AU2015242984A1 (en) 2015-11-05
US20170326111A1 (en) 2017-11-16
EA201171215A1 (ru) 2012-07-30
PT2413899T (pt) 2021-03-30
US20170319547A1 (en) 2017-11-09
US20160184269A1 (en) 2016-06-30
WO2010114622A1 (en) 2010-10-07
US20200268715A1 (en) 2020-08-27
US20140234421A1 (en) 2014-08-21
KR101747979B1 (ko) 2017-06-15
ZA201107011B (en) 2014-03-26
BRPI1010303A2 (pt) 2016-03-15
AU2010232995C1 (en) 2016-01-28
EP2413899A1 (en) 2012-02-08
AU2010232995B2 (en) 2015-07-16
MX2011010445A (es) 2012-01-19
NZ612063A (en) 2015-02-27

Similar Documents

Publication Publication Date Title
DK2413899T3 (da) Dentalt anæstetikum omfattende tetracain og en vasokonstriktor til intranasal indgivelse
NO2017033I1 (no) baricitinib og farmasøytisk akseptable salter derav
DK2509662T3 (da) Drivindretning til en lægemiddeladministrationsanordning og lægemiddeladministrationsanordning
DK2437830T4 (da) Anordning til lægemiddelleveringsindretning og lægemiddelleveringsindretning
DK3092901T3 (da) Quinolonanaloger og fremgangsmåder relateret dertil
HUE057713T2 (hu) A protein A (SPA) variánsaival kapcsolatos készítmények és módszerek
DK2337568T3 (da) Fremgangsmåder og midler til blødvævsteknologi
DK2320911T3 (da) Vasokonstriktionspræparater og fremgangsmåder til anvendelse deraf
DK2467173T3 (da) Sårbandager, fremgangsmåder til anvendelse heraf og fremgangsmåder til dannelse deraf
DK2358669T3 (da) Alpha-keto-persyrer og fremgangsmåder til fremstilling og anvendelse heraf
DK2649812T3 (da) Høreapparat og en fremgangsmåde til at forbedre talegengivelse
DK3318255T3 (da) Sammensætninger og fremgangsmåder til behandling af slagtilfælde hos en patient på samtidig statin-terapi
DK2254634T3 (da) Inhalator og sigte til en inhalator
DK2254590T3 (da) Fremgangsmåder og præparater til oral administration af insulin
NO346516B1 (no) Brønnbehandlingsfremgangsmåte for pressing og gruspakking
DK2493531T4 (da) Lægemiddelfremføringsindretninger og fremgangsmåde til samling
DK2432993T3 (da) En vindmølle og fremgangsmåde
DK3460056T3 (da) Terapeutiske nukleasesammensætninger og fremgangsmåder
DK2222675T3 (da) 5-anilinoimidazopyridiner og fremgangsmåder til deres anvendelse
DK3599279T3 (da) Sammensætninger og fremgangsmåder, som omfatter proteasevarianter
HUE036174T2 (hu) Eljárások vakcina beadására
DK3578215T3 (da) Lægemiddelfremføringsanordning og fremgangsmåde til en lægemiddelfremføringsanordning
DK3263100T3 (da) L-ornithinphenylacetat og fremgangsmåder til fremstilling deraf
NL301214I2 (nl) Lasmiditan en farmaceutisch aanvaardbare zouten daarvan
DK2475649T3 (da) Indenonderivat og farmaceutisk sammensætning omfattende samme